Sign up to save your podcasts
Or
Share Excess Apolipoprotein-B and Cardiovascular Risk, Treating Pulmonary Arterial Hypertension, SGLT2i and CV Outcomes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Excess Apolipoprotein-B and Cardiovascular Risk, Treating Pulmonary Arterial Hypertension, SGLT2i and CV Outcomes
In this week’s View, Dr. Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
128128 ratings
In this week’s View, Dr. Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes.
Subscribe to Eagle’s Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
139 Listeners
NEJM This Week
322 Listeners
JACC This Week
170 Listeners
This Week in Cardiology
872 Listeners
JAMA Clinical Reviews
502 Listeners
Circulation on the Run
31 Listeners
Mayo Clinic Talks
282 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
60 Listeners
ACC CardiaCast
38 Listeners
Annals On Call Podcast
195 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners
Mayo Clinic Cardiovascular CME
38 Listeners